Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis

被引:135
作者
Takahashi, F
Takahashi, K
Okazaki, T
Maeda, K
Ienaga, H
Maeda, M
Kon, S
Uede, T
Fukuchi, Y
机构
[1] Atopy Allergy Res Ctr, Dept Resp Med, Tokyo, Japan
[2] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan
[3] Immunobiol Labs Co Ltd, Gunma, Japan
[4] Hokkaido Univ, Inst Med Genet, Res Sect Mol Pathogenesis, Div Mol Immunol, Sapporo, Hokkaido, Japan
关键词
D O I
10.1165/ajrcmb.24.3.4293
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pulmonary fibrosis is initiated by migration, adhesion, and proliferation of fibroblasts. Osteopontin (OPN) is one of the cytokines produced by activated macrophages and mediates various functions, including cell attachment and migration, by interacting with alphav integrin. in this study, we have investigated the role of OPN in the pathogenesis of pulmonary fibrosis. We developed a mouse model for pulmonary fibrosis by intratracheal instillation of bleomycin (BLM). OPN was strongly expressed in alveolar macrophages accumulating in the fibrotic area of the lung. OPN messenger RNA (mRNA) in the lung was notably induced by BLM instillation, and the development of the fibrotic process was associated with an increase in the expression of OPN mRNA and protein. In vitro, recombinant OPN enhanced migration, adhesion, and platelet-derived growth factor (PDGF)-mediated DNA synthesis of murine fibroblast cell line NIH3T3. These effects of OPN on fibroblasts were significantly suppressed by addition of antimouse alphav integrin monoclonal antibody (RMV-7). Furthermore, treatment of mice with RMV-7 repressed the extent of pulmonary fibrosis in this model. Conclusively, these data suggest that OPN produced by alveolar macrophages functions as a fibrogenic cytokine that promotes migration, adhesion, and proliferation of fibroblasts in the development of BLM-induced pulmonary fibrosis.
引用
收藏
页码:264 / 271
页数:8
相关论文
共 56 条
[1]   PLATELET-DERIVED GROWTH-FACTOR IN IDIOPATHIC PULMONARY FIBROSIS [J].
ANTONIADES, HN ;
BRAVO, MA ;
AVILA, RE ;
GALANOPOULOS, T ;
NEVILLEGOLDEN, J ;
MAXWELL, M ;
SELMAN, M .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (04) :1055-1064
[2]   SIMPLE METHOD OF ESTIMATING SEVERITY OF PULMONARY FIBROSIS ON A NUMERICAL SCALE [J].
ASHCROFT, T ;
SIMPSON, JM ;
TIMBRELL, V .
JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (04) :467-470
[3]   Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity [J].
Ashkar, S ;
Weber, GF ;
Panoutsakopoulou, V ;
Sanchirico, ME ;
Jansson, M ;
Zawaideh, S ;
Rittling, SR ;
Denhardt, DT ;
Glimcher, MJ ;
Cantor, H .
SCIENCE, 2000, 287 (5454) :860-864
[4]   TRANSFORMING GROWTH FACTOR-BETA-1 IS PRESENT AT SITES OF EXTRACELLULAR-MATRIX GENE-EXPRESSION IN HUMAN PULMONARY FIBROSIS [J].
BROEKELMANN, TJ ;
LIMPER, AH ;
COLBY, TV ;
MCDONALD, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) :6642-6646
[5]   ALVEOLITIS AND COLLAPSE IN THE PATHOGENESIS OF PULMONARY FIBROSIS [J].
BURKHARDT, A .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (02) :513-524
[6]   PATHOGENESIS OF PULMONARY FIBROSIS [J].
BURKHARDT, A .
HUMAN PATHOLOGY, 1986, 17 (09) :971-973
[7]  
BUTLER WT, 1995, ANN NY ACAD SCI, V760, P6, DOI 10.1111/j.1749-6632.1995.tb44615.x
[8]  
Carlson I, 1997, LAB INVEST, V77, P103
[9]  
CHEN Y, 1992, J BIOL CHEM, V267, P24871
[10]   Pulmonary fibrosis: cytokines in the balance [J].
Coker, RK ;
Laurent, GJ .
EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (06) :1218-1221